Michael Landsittel
2017
In 2017, Michael Landsittel earned a total compensation of $842.9K as Vice President, Finance at Blueprint Medicines, a 91% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $93,154 |
|---|---|
| Option Awards | $481,056 |
| Salary | $260,936 |
| Other | $7,746 |
| Total | $842,892 |
Landsittel received $481.1K in option awards, accounting for 57% of the total pay in 2017.
Landsittel also received $93.2K in non-equity incentive plan, $260.9K in salary and $7.7K in other compensation.
Rankings
In 2017, Michael Landsittel's compensation ranked 9,800th out of 14,666 executives tracked by ExecPay. In other words, Landsittel earned more than 33.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,800 out of 14,666 | 33rd |
Division Manufacturing | 3,792 out of 5,772 | 34th |
Major group Chemicals And Allied Products | 1,318 out of 2,075 | 37th |
Industry group Drugs | 1,065 out of 1,731 | 39th |
Industry Pharmaceutical Preparations | 836 out of 1,333 | 37th |
Source: SEC filing on April 27, 2018.
Landsittel's colleagues
We found six more compensation records of executives who worked with Michael Landsittel at Blueprint Medicines in 2017.
2017
Jeffrey Albers
Blueprint Medicines
Chief Executive Officer
2017
Christopher Murray
Blueprint Medicines
Senior Vice President, Technical Operations
2017
Anthony Boral
Blueprint Medicines
Chief Medical Officer
2017
Kathryn Haviland
Blueprint Medicines
Chief Operating Officer
2017
Kate Haviland
Blueprint Medicines
Chief Business Officer
2017
Tracey McCain
Blueprint Medicines